CCPDMA is an advanced surgical treatment used to remove non-melanoma skin cancers, like basal cell carcinoma and squamous cell carcinoma. CCPDMA is designed to provide the highest cure rate of any form of skin cancer removal and at the same time limit the loss of unaffected (normal) tissue. It is for this reason that CCPDMA is most suitable for skin cancers on the head and neck, where limiting the removal of normal tissue on critical facial areas (eyelids, nose, forehead, cheeks, ears, and lips) greatly improves the final aesthetic and functional outcome by limiting scarring and permanent disfigurement.
Tumour cells often extend beyond the visible tumour – these tumour cells are not visible to the naked eye. However, CCPDMA includes immediate examination of the resected (surgically removed) tissue with microscopic analysis allowing the surgeon to track the removal of the cancer and ensure the complete elimination of all tumour. Cure rates for CCPDMA are close to 99% for most primary (untreated) cancers with a slightly lower cure rate for secondary or recurrent (previously treated) cancers. This cutting-edge treatment requires expertise in surgery, pathology and reconstructive surgery. There is a Pathologist with the team during the surgery
This procedure relies on the following highly specialized and controlled sequence of surgical tumour resection and pathological analysis:
You should expect the highest possible cure rate for your skin cancer of any treatment method offered anywhere in the world. Second, you should expect the sacrifice of the least amount of uninvolved tissue possible.
Patients undergoing CCPDMA are often surprised by: